In this issue
Diet, nutrition and cancer: public, media and scientific confusion
Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988–2007)
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer
Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score
Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: clinical activity and biological correlations
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies
Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa
A prospective study of pulmonary function in Hodgkin's lymphoma patients
Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma
Non-thromboembolic pulmonary hypertension in multiple myeloma, after thalidomide treatment: A pilot study
Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma
Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study
About sorafenib in castration-resistant prostate cancer
About sorafenib in castration-resistant prostate cancer
Chemotherapy for breast cancer during pregnancy: is epirubicin safe?
Trastuzumab in inflammatory breast cancer
Bevacizumab in advanced cancer, too much or too little?